Hedge Fund and Insider Trading News: Ray Dalio, Warren Buffett, Soros Fund Management, Lansdowne Partners, Altus Strategies PLC (ALTUF), Crispr Therapeutics AG (CRSP), and More

New Hedge Fund Launches at 175 Exceed Liquidations in 4Q20 (Opalesque.com)
New hedge fund launches increased to an estimated 175 in 4Q20 and exceeded the estimated quarterly liquidations for the second consecutive quarter, after eight quarters of contraction, said a report. According to the latest HFR Market Microstructure Report, launches in 4Q exceeded the 3Q estimate of 151 new funds, bringing the FY 2020 launches to 539, a period which included a record low number of launches in 1Q as the global pandemic began.

Hedge Fund Lansdowne to Spin-Off New Energy-Focused Company (Reuters)
LONDON (Reuters) – London-based hedge fund Lansdowne Partners plans to spin off two funds managed by one of its partners into a new company later this year, it said in a statement on Thursday. The company will be headed by Per Lekander and will be called Clean Energy Transition LLP.

Griffin’s Covid Year Had Planes, Palm Beach, Philanthropy (Bloomberg)
In the early days of the pandemic, Ken Griffin talked with President Donald Trump and Vice President Mike Pence about stimulus and fast-tracking Covid therapies. Now, he sees an opening to work with the Biden administration to address a year of lost learning. “The political party doesn’t matter to me,” said Griffin, 52, who contributed $66 million to Republicans in the last election. “What matters is the receptivity to solving the problem.”

Crispr Therapeutics Ag (CRSP) CBO & COO Lawrence Otto Klein Sold $12.8 million of Shares (Guru Focus)
CBO & COO of Crispr Therapeutics Ag, Lawrence Otto Klein, sold 100,000 shares of CRSP on 03/23/2021 at an average price of $128.05 a share. The total sale was $12.8 million. CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. Crispr Therapeutics Ag has a market cap of $8.64 billion; its shares were traded at around $114.600000 with and P/S ratio of 10418.19.

The Shareholder of Altus Strategies PLC (Other OTC: ALTUF) is Buying Shares (Analyst Ratings)
Yesterday, the Shareholder of Altus Strategies PLC (ALTUF), La Mancha Holding S.A.R.L., bought shares of ALTUF for $4.73M. Following this transaction La Mancha Holding S.A.R.L.’s holding in the company was increased by 15% to a total of $30.33 million. In addition to La Mancha Holding S.A.R.L., 5 other ALTUF executives reported Buy trades in the last month.

Follow Insider Monkey on Twitter